Vimarsana
Biggest News Aggregation in the World

Page 10 - Peter Altman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Altman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Altman Today - Breaking & Trending Today

BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed - Vimarsana News

BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed

SUNNYVALE, Calif., Feb. 14, 2022 -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today... | February 14, 2022

Alzheimer's Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases - Vimarsana News

Alzheimer's Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimer's disease (AD) is the most common reason of progressive dementia in the elderly population....

Financialnewsmedia.com: Alzheimer's Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases - Vimarsana News

Financialnewsmedia.com: Alzheimer's Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases

PALM BEACH, Fla., Jan. 5, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimer's disease (AD) is the most common reason of progressive dementia in the elderly population.

Alzheimer's Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases - Vimarsana News

Alzheimer's Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimer's disease (AD) is the most common reason of progressive dementia in the elderly population....

BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial ... - Vimarsana News

BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com